AB 1853
8 links on this map: who funds them, what they touched, and who lobbied on it. Select anyone to move the map to them.
Start with
and connect to
Zoom to read. Drag to explore. Select a connection.
AB 1853
Health care: drug costs
California · Failed
Every link on this map
The same connections as a table, with the reason each one is here.
| Amga | Lobbied on it | Amga named AB 1853 in 3 lobbying reports. | 3 reports |
| GSK | Lobbied on it | GSK named AB 1853 in 3 lobbying reports. | 3 reports |
| Pharmacia | Lobbied on it | Pharmacia named AB 1853 in 3 lobbying reports. | 3 reports |
| Aids Healthcare Foundation | Lobbied on it | Aids Healthcare Foundation named AB 1853 in 2 lobbying reports. | 2 reports |
| Astrazeneca Pharmaceuticals, LP | Lobbied on it | Astrazeneca Pharmaceuticals, LP named AB 1853 in 2 lobbying reports. | 2 reports |
| Lilly USA | Lobbied on it | Lilly USA named AB 1853 in 2 lobbying reports. | 2 reports |
| Schering Corporation | Lobbied on it | Schering Corporation named AB 1853 in 2 lobbying reports. | 2 reports |
| Wyeth | Lobbied on it | Wyeth named AB 1853 in 2 lobbying reports. | 2 reports |